(VIANEWS) – POLARIS MEDIA (POL.OL), UCB (UCB.BR), OKEA (OKEA.OL) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio so far. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. POLARIS MEDIA (POL.OL)
555.56% Payout Ratio
Polaris Media ASA operates as a media house and printing company in Norway and Sweden. The company provides digital advertising services. It also prints group and external newspapers, including editorial supplements, advertising supplements and newspapers, civil prints, and other magazines/supplements. In addition, the company distributes newspapers, as well as parcels, mails, and food deliveries. The company was founded in 2008 and is headquartered in Trondheim, Norway.
Earnings Per Share
As for profitability, POLARIS MEDIA has a trailing twelve months EPS of kr0.27.
PE Ratio
POLARIS MEDIA has a trailing twelve months price to earnings ratio of 281.48. Meaning, the purchaser of the share is investing kr281.48 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.47%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on May 5, 2023, the estimated forward annual dividend rate is 1.5 and the estimated forward annual dividend yield is 2.08%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
POLARIS MEDIA’s EBITDA is 42.9.
Yearly Top and Bottom Value
POLARIS MEDIA’s stock is valued at kr76.00 at 21:10 EST, below its 52-week high of kr77.00 and way above its 52-week low of kr47.20.
Volume
Today’s last reported volume for POLARIS MEDIA is 866 which is 75.87% below its average volume of 3590.
More news about POLARIS MEDIA.
2. UCB (UCB.BR)
78.24% Payout Ratio
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; BIMZELX for treating psoriasis, psoriatic arthritis, axial spondyloarthritis, and hidradenitis suppurativa; and dapirolizumab pegol for systemic lupus erythematosus. In addition, the company is involved in developing rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; zilucoplan to treat myasthenia gravis and immune-mediated necrotizing myopathy; staccato alprazolam to treat tereotypical prolonged seizure; Bepranemab to treat Alzheimer's disease; and UCB0599 to treat Parkinson's disease. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, Otsuka, and doc.ai. It operates in the United States, Japan, Germany, rest of Europe, Spain, France, China, Italy, the United Kingdom, Ireland, Belgium, and internationally. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, UCB has a trailing twelve months EPS of €1.7.
PE Ratio
UCB has a trailing twelve months price to earnings ratio of 48.58. Meaning, the purchaser of the share is investing €48.58 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.7%.
Yearly Top and Bottom Value
UCB’s stock is valued at €82.58 at 21:10 EST, under its 52-week high of €88.80 and way higher than its 52-week low of €65.40.
Moving Average
UCB’s value is way higher than its 50-day moving average of €73.54 and above its 200-day moving average of €79.64.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Apr 28, 2023, the estimated forward annual dividend rate is 1.33 and the estimated forward annual dividend yield is 1.58%.
More news about UCB.
3. OKEA (OKEA.OL)
63.8% Payout Ratio
OKEA ASA, an oil and gas company, engages in the development and production of oil and gas in the Norwegian continental shelf. The company holds 44.56% interests in Draugen, 12% interests in Gjøa, 9.2385% interests in Ivar Aasen, 6% interests in Nova, and 15% interests in Yme assets. OKEA ASA was incorporated in 2015 and is headquartered in Trondheim, Norway.
Earnings Per Share
As for profitability, OKEA has a trailing twelve months EPS of kr6.27.
PE Ratio
OKEA has a trailing twelve months price to earnings ratio of 3.75. Meaning, the purchaser of the share is investing kr3.75 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.98%.
More news about OKEA.
4. FBD HOLDINGS PLC (EG7.IR)
56.82% Payout Ratio
FBD Holdings plc, through its subsidiaries, engages in the underwriting of general insurance to farmers, private individuals, and business owners in Ireland. The company operates in two segments, Underwriting and Financial Services. It offers car, home, travel, life and pension, business, farm, and business insurance products, as well as insurance related to motor, fire, liability, and other damage to property. The company also provides investment, pension brokerage, and employee services; and engages in re-insurance activities. FBD Holdings plc was founded in 1969 and is headquartered in Dublin, Ireland.
Earnings Per Share
As for profitability, FBD HOLDINGS PLC has a trailing twelve months EPS of €1.76.
PE Ratio
FBD HOLDINGS PLC has a trailing twelve months price to earnings ratio of 6.65. Meaning, the purchaser of the share is investing €6.65 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.11%.
Moving Average
FBD HOLDINGS PLC’s worth is above its 50-day moving average of €11.28 and below its 200-day moving average of €12.44.
Revenue Growth
Year-on-year quarterly revenue growth grew by 18.5%, now sitting on 366.34M for the twelve trailing months.
More news about FBD HOLDINGS PLC.
5. GIMV (GIMB.BR)
40.56% Payout Ratio
Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer 2020; Connected Consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer 2020, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. It mainly focuses on European market and midcap companies in Flanders and Brussels, and also invests in Kazakhstan, Benelux, Germany, France, Italy, Luxembourg, Netherlands, United Kingdom, Russia, Czech Republic, and Slovakia. Within consumer 2020, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. It invests in small and medium sized businesses primarily with headquarters in the Benelux, France, and Germany with an enterprise value of up to €125 million ($144.76 million). It seeks to invest between €3 million ($3.47 million) to €30 million ($34.74 million). Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies with headquarters in Benelux, France and DACH region. It typically makes investments between €3 million ($3.47 million) to €10 million ($11.58 million) in the biopharma and medtech and between €10 million ($11.58 million) to €30 million ($34.74 million) in the health and care services. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced computation power, and components and systems for efficient use of energy, in terms of production, storage, management, use and transport sectors. It focuses on B2B products and services, based on innovation, advanced engineering, advanced manufacturing or software. It invests in companies with an enterprise value of up to €125 million ($144.76 million). It also makes flexible equity investment (equity, semi-equity, minority or majority) but always with a meaningful impact on the company and an exit trigger. It seeks to invest between €3 million ($3.47 million) to €30 million ($34.74 million). Within sustainable cities, it focuses on Products, services and infrastructure for building sustainable urban societies: Utilities and consumer goods related to energy and other (raw) materials, Waste treatment, recycling and recovery, Construction and Infrastructure, Transport and Logistics Services, and biomass, green (sustainable) chemistry, water, offshore and maritime solutions and energy efficient infrastructure. It invests through (mezzanine, equity, minority or majority) but will always strive to have a meaningful impact on the company strategy and need an exit trigger. It also invests in semiconductors, chemicals, agriculture, clean technology, electronics, water processing and purification technologies. It seeks to invest in small to medium companies with headquarters in the Benelux, France and Germany (DACH) targeting an international customer base. For fund of fund investments, it seeks to invest in Europe. It typically invests between $2.9 million and $425.439 million in companies with an enterprise value between $86.85 million and $868.55 million and sales value ranging from $6.67 million to $567.252 million. It may take a majority or a minority stake in its portfolio companies. Its investment horizon is between four and seven years. It also seeks a board seat in its portfolio companies. It invests with capital from its own balance sheet and through various funds under management. Gimv NV was founded on February 25, 1980 and is based in Antwerp, Belgium with additional offices in Paris, France; Hague, The Netherlands; Frankfurt am Main, Germany; London, United Kingdom; Prague, Czech Republic; Warsaw, Poland; and Munich, Germany.
Earnings Per Share
As for profitability, GIMV has a trailing twelve months EPS of €6.41.
PE Ratio
GIMV has a trailing twelve months price to earnings ratio of 6.66. Meaning, the purchaser of the share is investing €6.66 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.99%.
Volume
Today’s last reported volume for GIMV is 16053 which is 14.45% above its average volume of 14025.
More news about GIMV.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Volume
Today’s last reported volume for 1 is 1 which is 1% above its average volume of 1.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 1%.
Sales Growth
1’s sales growth is 1% for the present quarter and 1% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1%, now sitting on 1 for the twelve trailing months.
More news about 1.
